Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
China Health Technology Group Holding Co Debt-to-Equity Related Terms
China Health Technology Group Holding Co Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co Debt-to-Equity Chart
China Health Technology Group Holding Co Annual Data
CHBOF vs SSD, UFPI, BCC: Debt-to-Equity Comparison
For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Technology Group Holding Co Debt-to-Equity vs Forest Products Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Technology Group Holding Co (CHBOF) has a Debt-to-Equity of 2.02 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on China Health Technology Group Holding Co and its competitors. This is 106% above median its historical median of 0.98. According to the industry distribution chart, China Health Technology Group Holding Co ranks #237 out of 256 companies in the Forest Products industry, placing it in the top 92.6%.
Is China Health Technology Group Holding Co's Debt-to-Equity too high?
China Health Technology Group Holding Co's current Debt-to-Equity of 2.02 is 106% above median its 10-year median of 0.98. The Forest Products industry median Debt-to-Equity is 0.49. China Health Technology Group Holding Co's value of 2.02 is 316.5% above this industry median. Based on the distribution chart, China Health Technology Group Holding Co ranks #237 out of 256 companies in the Forest Products industry, which is in the bottom quartile relative to peers. Overall, China Health Technology Group Holding Co has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Debt-to-Equity compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #237 out of 256 companies for Debt-to-Equity. This places China Health Technology Group Holding Co in the lower half of its industry. The industry median Debt-to-Equity is 0.49. China Health Technology Group Holding Co's value of 2.02 is 316.5% above this benchmark. While the company's 10-year median is 0.98 vs. the industry median of 0.49, China Health Technology Group Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Forest Products company?
The median Debt-to-Equity among Forest Products companies is 0.49, based on 256 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Health Technology Group Holding Co's current Debt-to-Equity of 2.02 is 316.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on China Health Technology Group Holding Co and its competitors. For the Forest Products industry, the median Debt-to-Equity is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Technology Group Holding Co's current Debt-to-Equity is 2.02, which is 106% above median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Debt-to-Equity of 2.02. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current Debt-to-Equity is 2.02, which is 106% above median its 10-year median of 0.98 and 316.5% above the Forest Products industry median of 0.49. China Health Technology Group Holding Co's overall GF Score™ is 28/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Debt-to-Equity is 2.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued.
The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.
Key valuation signals for CHBOF:
Debt-to-Equity: 2.02 (106% above median its 10-year median of 0.98)
GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
Industry Position: 316.5% above the Forest Products median (#237 of 256)
No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
28GF Score
Get the complete analysis for CHBOF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHBOF has been successfully added to your 
